BioCentury | Mar 6, 2021
Management Tracks

Winter to lead BeiGene’s European commerical ops; plus Dyne, Axcella, Prometheus and more

...global head of neuromuscular diseases, medical affairs at Biogen Inc. (NASDAQ:BIIB). Alison Schecter joined metabolic disease play Axcella Health Inc....
...previously served as CMO at Selecta Biosciences Inc. (NASDAQ:SELB). Manu Chakravarthy is stepping down as Axcella’s...
...to complete an IPO on KOSDAQ early this year. BC Staff BeiGene Ltd. eGenesis Inc. Omniome Inc. Bioventus Inc. Dyne Therapeutics Inc. Axcella Health Inc. Prometheus...
BioCentury | Aug 31, 2020
Deals

Takeout premium shows Nestlé’s faith in Aimmune peanut product, despite launch slowed by COVID

...company Seres Therapeutics Inc. (NASDAQ:MCRB), including a $20 million commitment this month; and metabolic play Axcella Health Inc....
BioCentury | Aug 8, 2020
Management Tracks

PacBio shifts executive team; plus changes at CMAB, Valo, Alentis, Amwell and more

...Heidy Abreu King-Jones as its first chief legal officer. She was SVP, general counsel at Axcella Health Inc....
BioCentury | Aug 7, 2020
Management Tracks

First chief diversity officer for Alexion; plus changes at WuXi, Dicerna, Valneva, MeiraGTx, Anika and more

...succeeds CMO Ralf Rosskamp, who is retiring. Aradhye was EVP and chief development officer of Axcella Health Inc....
BioCentury | May 6, 2020
Product Development

Phase II data show Novo’s semaglutide leads the pack on NASH resolution

...has invested heavily in building out a pipeline (see “Novo’s Year of Obesity” ). Separately, Axcella Health Inc....
BioCentury | Nov 27, 2019
Company News

Management tracks: Ultragenyx COO to step down next year; plus Agios, MiMedx, Iveric, Ardelyx, Novo Seeds, Axcella, NervGen

...to help the start-ups graduate to seed investment (see "Pharma Ventures Earlier" ). Flagship Pioneering-backed Axcella Health Inc....
...modulation company also promoted Heidy King-Jones to general counsel from VP of legal. Before joining Axcella...
...Notable Labs Inc. Elizabeth S. Eaton, Staff Writer Ultragenyx Pharmaceutical Inc. MiMedx Group Inc. Iveric bio Inc. Agios Pharmaceuticals Inc. Ardelyx Inc. Axcella Health Inc. NervGen...
BioCentury | Sep 13, 2019
Company News

Management tracks: Orchard, Black Diamond, ALK-Abelló, Menarini, Imvax, Rallybio, Milestone, MaaT and more

...Black Diamond Therapeutics Inc. (Cambridge, Mass.) hired Thomas Leggett as CFO. Leggett was CFO of Axcella Health Inc....
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...Inc. (NASDAQ:MIST) 5/8/19 $94.9 $367.1 $664.9 81% NextCure Inc. (NASDAQ:NXTC) 5/8/19 $86.3 $340.3 $340.3 0% Axcella Health Inc....
...device play Avedro Inc. the only outlier at $37 million raised in private money. Indeed, Axcella Health Inc....
...despite a pledge of $43 million in insider support for the IPO. On May 8, Axcella...
BioCentury | May 9, 2019
Finance

Cortexyme’s first-day pop leads IPO quartet amid choppy market

...all priced at the midpoint of their ranges ahead of Thursday’s session, while metabolic company Axcella Health Inc....
...had the best first-day results, gaining 93% during the session, while NextCure was up 33%. Axcella...
...III trial to treat paroxysmal supraventricular tachycardia, a heart rate condition (see “Milestone’s Options” ). Axcella...
BioCentury | Apr 30, 2019
Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

...viruses and liposomal candidates (see "Tot Raises $102M Series B" ). Axcella sets IPO terms Axcella Health Inc....
...the midpoint, Axcella would raise $75 million and be valued at $482.8 million (see "Flagship-Backed Axcella...
...as therapeutics. Telegraph Hill Partners led the newco’s undisclosed series A round. Elizabeth S. Eaton, Staff Writer Axcella Health Inc. Congenica...
Items per page:
1 - 10 of 33
BioCentury | Mar 6, 2021
Management Tracks

Winter to lead BeiGene’s European commerical ops; plus Dyne, Axcella, Prometheus and more

...global head of neuromuscular diseases, medical affairs at Biogen Inc. (NASDAQ:BIIB). Alison Schecter joined metabolic disease play Axcella Health Inc....
...previously served as CMO at Selecta Biosciences Inc. (NASDAQ:SELB). Manu Chakravarthy is stepping down as Axcella’s...
...to complete an IPO on KOSDAQ early this year. BC Staff BeiGene Ltd. eGenesis Inc. Omniome Inc. Bioventus Inc. Dyne Therapeutics Inc. Axcella Health Inc. Prometheus...
BioCentury | Aug 31, 2020
Deals

Takeout premium shows Nestlé’s faith in Aimmune peanut product, despite launch slowed by COVID

...company Seres Therapeutics Inc. (NASDAQ:MCRB), including a $20 million commitment this month; and metabolic play Axcella Health Inc....
BioCentury | Aug 8, 2020
Management Tracks

PacBio shifts executive team; plus changes at CMAB, Valo, Alentis, Amwell and more

...Heidy Abreu King-Jones as its first chief legal officer. She was SVP, general counsel at Axcella Health Inc....
BioCentury | Aug 7, 2020
Management Tracks

First chief diversity officer for Alexion; plus changes at WuXi, Dicerna, Valneva, MeiraGTx, Anika and more

...succeeds CMO Ralf Rosskamp, who is retiring. Aradhye was EVP and chief development officer of Axcella Health Inc....
BioCentury | May 6, 2020
Product Development

Phase II data show Novo’s semaglutide leads the pack on NASH resolution

...has invested heavily in building out a pipeline (see “Novo’s Year of Obesity” ). Separately, Axcella Health Inc....
BioCentury | Nov 27, 2019
Company News

Management tracks: Ultragenyx COO to step down next year; plus Agios, MiMedx, Iveric, Ardelyx, Novo Seeds, Axcella, NervGen

...to help the start-ups graduate to seed investment (see "Pharma Ventures Earlier" ). Flagship Pioneering-backed Axcella Health Inc....
...modulation company also promoted Heidy King-Jones to general counsel from VP of legal. Before joining Axcella...
...Notable Labs Inc. Elizabeth S. Eaton, Staff Writer Ultragenyx Pharmaceutical Inc. MiMedx Group Inc. Iveric bio Inc. Agios Pharmaceuticals Inc. Ardelyx Inc. Axcella Health Inc. NervGen...
BioCentury | Sep 13, 2019
Company News

Management tracks: Orchard, Black Diamond, ALK-Abelló, Menarini, Imvax, Rallybio, Milestone, MaaT and more

...Black Diamond Therapeutics Inc. (Cambridge, Mass.) hired Thomas Leggett as CFO. Leggett was CFO of Axcella Health Inc....
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...Inc. (NASDAQ:MIST) 5/8/19 $94.9 $367.1 $664.9 81% NextCure Inc. (NASDAQ:NXTC) 5/8/19 $86.3 $340.3 $340.3 0% Axcella Health Inc....
...device play Avedro Inc. the only outlier at $37 million raised in private money. Indeed, Axcella Health Inc....
...despite a pledge of $43 million in insider support for the IPO. On May 8, Axcella...
BioCentury | May 9, 2019
Finance

Cortexyme’s first-day pop leads IPO quartet amid choppy market

...all priced at the midpoint of their ranges ahead of Thursday’s session, while metabolic company Axcella Health Inc....
...had the best first-day results, gaining 93% during the session, while NextCure was up 33%. Axcella...
...III trial to treat paroxysmal supraventricular tachycardia, a heart rate condition (see “Milestone’s Options” ). Axcella...
BioCentury | Apr 30, 2019
Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

...viruses and liposomal candidates (see "Tot Raises $102M Series B" ). Axcella sets IPO terms Axcella Health Inc....
...the midpoint, Axcella would raise $75 million and be valued at $482.8 million (see "Flagship-Backed Axcella...
...as therapeutics. Telegraph Hill Partners led the newco’s undisclosed series A round. Elizabeth S. Eaton, Staff Writer Axcella Health Inc. Congenica...
Items per page:
1 - 10 of 33